Constitutional Accountability Center Constitutional Accountability Center
Corporate Accountability

RADIO (KCRW/NPR): Obamacare’s Survival on the Line Again

For the second time, the US Supreme Court is considering a challenge to the Affordable Care Act. Federal health insurance subsidies for seven million Americans will depend on how the Justices rule on arguments they heard today. Discussion includes CAC Chief Counsel Elizabeth Wydra.

More from Corporate Accountability

Corporate Accountability
U.S. Supreme Court

Federal Communications Commission v. AT&T and Verizon v. Federal Communications Commission

In Federal Communications Commission v. AT&T and Verizon v. Federal Communications Commission, the Supreme Court is considering whether the FCC’s two-stage civil-enforcement process violates the Seventh Amendment.
Corporate Accountability
January 15, 2026

January Newsletter: CAC Keeps Up the Fight for Corporate Accountability
Corporate Accountability
U.S. Court of Appeals for the Sixth Circuit

Millennia Housing Management v. Department of Housing and Urban Development

In Millennia Housing Management v. Department of Housing and Urban Development, the United States Court of Appeals for the Sixth Circuit is considering a challenge to the Department of Housing and Urban Development’s authority to...
Corporate Accountability
July 2, 2025

Moneyed Interests Still Prevail at the Supreme Court (2024-2025 Term)

The Court Continues to Favor Corporations over Workers, Consumers, and the Environment.
By: Brian R. Frazelle, Ana Builes
Corporate Accountability
U.S. Court of Appeals for the Third Circuit

Novartis v. Secretary United States Department of Health and Human Services

In Novartis v. Secretary United States Department of Health and Human Services, the United States Court of Appeals for the Third Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional...
Corporate Accountability
U.S. Court of Appeals for the Second Circuit

Boehringer Ingelheim v. Department of Health and Human Services

In Boehringer Ingelheim v. Department of Health and Human Services, the United States Court of Appeals for the Second Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional taking...